Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06846047 · ClinicalTrials.gov registry record · NA
Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait
A NA study of Vestibulopathy, sponsored by Neursantys.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 4
- Study locations
NCT06846047: Recruiting NA study of Vestibulopathy, sponsored by Neursantys.
NCT06846047 is a NA study of Vestibulopathy that is actively recruiting participants, run by Neursantys. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06846047, a NA study of Vestibulopathy, is actively recruiting participants, sponsored by Neursantys.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The aim of the study to is determine the safety, feasibility, efficacy, and persistence of non-invasive EVS to improve balance and gait performance in healthy individuals across the lifespan. Specifically, our objective is to measure balance and gait performance before, during and after exposure to single sessions and across repeated sequences of EVS at multiple study partner sites.
Primary Outcome
Postural sway will be calculated from acceleration profiles of the head measured using data from a head-mounted accelerometer in eyes open and eyes closed conditions. The raw acceleration signals are in units of G. The outcome measure is expressed as a sway power value (in Watts). Sway power measured during static standing has been shown to be a precise, quickly administered assessment of balance performance with excellent sensitivity in the identification of older adult fallers. We will complet
Conditions Studied
Interventions
- DEVICE Sham Comparator
- DEVICE electrical vestibular stimulation (EVS)
Study Locations (4)
California
- Caring Hands Caregivers - Cupertino
- Neursantys - Menlo Park
Alberta
- University of Calgary - Calgary
New Brunswick
- Sparx Wellness Institute - Dieppe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT06846047 shows while recruiting
NCT06846047 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Vestibulopathy appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.
NCT06846047 reports a single indexed study location in California, Alberta, New Brunswick.
Frequently Asked Questions
What is clinical trial NCT06846047 about?
NCT06846047 is a clinical study titled "Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait". The aim of the study to is determine the safety, feasibility, efficacy, and persistence of non-invasive EVS to improve balance and gait performance in healthy individuals across the lifespan. Specifically, our objective is to measure balance and gait performance before, during and after exposure to ...
What is the current status of trial NCT06846047?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-01-20. Estimated completion is 2027-02-28.
What conditions does trial NCT06846047 study?
This clinical trial studies the following conditions: Vestibulopathy.
What interventions are being tested in trial NCT06846047?
The interventions under investigation include: Sham Comparator (DEVICE), electrical vestibular stimulation (EVS) (DEVICE).
Who is sponsoring clinical trial NCT06846047?
This trial is sponsored by Neursantys, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06846047 being conducted?
This trial has 4 study locations across California, Alberta, New Brunswick. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06846047's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,789 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI